BRPI0606115A2 - processos para a preparação de compostos éteres de pirazol [3,4-d] pirimidina - Google Patents
processos para a preparação de compostos éteres de pirazol [3,4-d] pirimidinaInfo
- Publication number
- BRPI0606115A2 BRPI0606115A2 BRPI0606115-0A BRPI0606115A BRPI0606115A2 BR PI0606115 A2 BRPI0606115 A2 BR PI0606115A2 BR PI0606115 A BRPI0606115 A BR PI0606115A BR PI0606115 A2 BRPI0606115 A2 BR PI0606115A2
- Authority
- BR
- Brazil
- Prior art keywords
- processes
- pyrazol
- ether compounds
- preparation
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
PROCESSOS PARA A PREPARAçãO DE COMPOSTOS DE éTERES DE PIRAZOL[3,4-d]PIRIMIDINA. A presente invenção refere-se a processos para preparação de compostos de éteres de pirazol[3,4-d]pirimidina que são moduladores de metabolismo de glicose e, portanto, úteis no tratamento de doenças metabólicas, tais como diabetes e obesidade.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64371205P | 2005-01-13 | 2005-01-13 | |
PCT/US2006/001020 WO2006076455A2 (en) | 2005-01-13 | 2006-01-12 | Processes for preparing pyrazolo[3,4-d]pyrimidine ethers |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0606115A2 true BRPI0606115A2 (pt) | 2009-06-02 |
Family
ID=36463499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0606115-0A BRPI0606115A2 (pt) | 2005-01-13 | 2006-01-12 | processos para a preparação de compostos éteres de pirazol [3,4-d] pirimidina |
Country Status (22)
Country | Link |
---|---|
US (1) | US7425630B2 (pt) |
EP (1) | EP1838713A2 (pt) |
JP (1) | JP2008526975A (pt) |
KR (1) | KR20070114126A (pt) |
CN (1) | CN101142216A (pt) |
AR (1) | AR052557A1 (pt) |
AU (1) | AU2006204940A1 (pt) |
BR (1) | BRPI0606115A2 (pt) |
CA (1) | CA2593345A1 (pt) |
CR (1) | CR9224A (pt) |
DO (1) | DOP2006000009A (pt) |
EA (1) | EA013968B1 (pt) |
GT (1) | GT200600011A (pt) |
HN (1) | HN2006001493A (pt) |
IL (1) | IL184365A0 (pt) |
MX (1) | MX2007008381A (pt) |
NO (1) | NO20074052L (pt) |
PA (1) | PA8659701A1 (pt) |
PE (1) | PE20061118A1 (pt) |
TW (1) | TW200637865A (pt) |
WO (1) | WO2006076455A2 (pt) |
ZA (1) | ZA200705279B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10238722A1 (de) | 2002-08-23 | 2004-03-11 | Bayer Ag | Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse |
ATE374766T1 (de) | 2003-01-14 | 2007-10-15 | Arena Pharm Inc | 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie |
MXPA06000554A (es) * | 2003-07-14 | 2006-07-03 | Arena Pharm Inc | Derivados arilo y heteroarilo fusionados como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con los mismos. |
US7923465B2 (en) * | 2005-06-02 | 2011-04-12 | Glenmark Pharmaceuticals S.A. | Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
CA2706018C (en) | 2007-11-30 | 2015-11-24 | Boehringer Ingelheim International Gmbh | 1, 5-dihydro-pyrazolo [3,4-d]pyrimidin-4-one derivatives and their use as pde9a modulators for the treatment of cns disorders |
UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
EP2318404B1 (en) * | 2008-07-16 | 2013-08-21 | Merck Sharp & Dohme Corp. | Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
US9079905B2 (en) | 2008-09-08 | 2015-07-14 | Boehringer Ingelheim International Gmbh | Compounds for the treatment of CNS disorders |
MY156377A (en) | 2009-03-31 | 2016-02-15 | Boehringer Ingelheim Int | 1-heterocycl-1, 5-dihydro-pyrazolo [3 , 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
US20100285145A1 (en) * | 2009-05-08 | 2010-11-11 | Pfizer Inc | Gpr 119 modulators |
KR20120061063A (ko) * | 2009-06-05 | 2012-06-12 | 화이자 인코포레이티드 | Gpr 119 조절제로서의 l-(피페리딘-4-일)-피라졸 유도체 |
EP3378854B1 (en) | 2010-01-27 | 2022-12-21 | Arena Pharmaceuticals, Inc. | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
GEP20156217B (en) | 2010-08-12 | 2015-01-12 | Boehringer Ingelheim Int | 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors |
BR112013008100A2 (pt) | 2010-09-22 | 2016-08-09 | Arena Pharm Inc | "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles." |
US8809345B2 (en) | 2011-02-15 | 2014-08-19 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
AU2012267556B9 (en) | 2011-06-09 | 2017-05-11 | Rhizen Pharmaceuticals Sa | Novel compounds as modulators of GPR-119 |
JP6567276B2 (ja) * | 2014-05-13 | 2019-08-28 | ソニーセミコンダクタソリューションズ株式会社 | 固体撮像素子、および電子機器 |
RU2709786C2 (ru) * | 2014-12-06 | 2019-12-20 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
US11007175B2 (en) | 2015-01-06 | 2021-05-18 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
NZ738862A (en) | 2015-06-22 | 2023-12-22 | Arena Pharm Inc | Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disorders |
CA3053418A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
JP2019122134A (ja) | 2018-01-04 | 2019-07-22 | Ntn株式会社 | スイッチング電源の力率改善用pwm制御装置 |
WO2022268935A2 (en) * | 2021-06-23 | 2022-12-29 | F. Hoffmann-La Roche Ag | Novel process |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3070304D1 (en) | 1980-04-28 | 1985-04-25 | Teijin Ltd | Thiazolo(3,2-a)pyrimidine derivatives, process for preparing same, and drug containing same |
EP0053678A1 (de) * | 1980-12-05 | 1982-06-16 | BASF Aktiengesellschaft | 5-Amino-1-phenyl-4-cyanpyrazole, diese enthaltende herbizide Mittel, Verfahren zu ihrer Herstellung und ihre Anwendung als Herbizide |
US4612376A (en) | 1983-03-25 | 1986-09-16 | Fujisawa Pharmaceutical Co., Ltd. | Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent |
GB9114760D0 (en) | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
JP4022271B2 (ja) | 1995-10-31 | 2007-12-12 | 富士フイルム株式会社 | ピラゾリルアゾフエノール色素 |
US6921763B2 (en) * | 1999-09-17 | 2005-07-26 | Abbott Laboratories | Pyrazolopyrimidines as therapeutic agents |
CA2385747A1 (en) * | 1999-09-17 | 2001-03-22 | Gavin C. Hirst | Pyrazolopyrimidines as therapeutic agents |
DE10219435A1 (de) | 2002-05-02 | 2003-11-13 | Bayer Cropscience Ag | Substituierte Pyrazolo-pyrimidin-4-one |
AU2003261204A1 (en) | 2002-07-23 | 2004-02-09 | Smithkline Beecham Corporation | Pyrazolopyrimidines as kinase inhibitors |
MXPA06000554A (es) * | 2003-07-14 | 2006-07-03 | Arena Pharm Inc | Derivados arilo y heteroarilo fusionados como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con los mismos. |
GB0425035D0 (en) | 2004-11-12 | 2004-12-15 | Novartis Ag | Organic compounds |
-
2006
- 2006-01-05 DO DO2006000009A patent/DOP2006000009A/es unknown
- 2006-01-09 TW TW095100806A patent/TW200637865A/zh unknown
- 2006-01-10 PE PE2006000054A patent/PE20061118A1/es not_active Application Discontinuation
- 2006-01-11 GT GT200600011A patent/GT200600011A/es unknown
- 2006-01-12 HN HN2006001493A patent/HN2006001493A/es unknown
- 2006-01-12 AU AU2006204940A patent/AU2006204940A1/en not_active Withdrawn
- 2006-01-12 WO PCT/US2006/001020 patent/WO2006076455A2/en active Application Filing
- 2006-01-12 CN CNA2006800064543A patent/CN101142216A/zh not_active Withdrawn
- 2006-01-12 KR KR1020077018365A patent/KR20070114126A/ko not_active Application Discontinuation
- 2006-01-12 MX MX2007008381A patent/MX2007008381A/es active IP Right Grant
- 2006-01-12 CA CA002593345A patent/CA2593345A1/en not_active Withdrawn
- 2006-01-12 US US11/331,372 patent/US7425630B2/en not_active Expired - Fee Related
- 2006-01-12 EA EA200701500A patent/EA013968B1/ru not_active IP Right Cessation
- 2006-01-12 EP EP06718131A patent/EP1838713A2/en not_active Withdrawn
- 2006-01-12 BR BRPI0606115-0A patent/BRPI0606115A2/pt not_active IP Right Cessation
- 2006-01-12 PA PA20068659701A patent/PA8659701A1/es unknown
- 2006-01-12 JP JP2007551363A patent/JP2008526975A/ja not_active Withdrawn
- 2006-01-12 AR ARP060100122A patent/AR052557A1/es not_active Application Discontinuation
-
2007
- 2007-07-02 IL IL184365A patent/IL184365A0/en unknown
- 2007-07-03 CR CR9224A patent/CR9224A/es unknown
- 2007-07-06 ZA ZA200705279A patent/ZA200705279B/xx unknown
- 2007-08-06 NO NO20074052A patent/NO20074052L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200705279B (en) | 2008-11-26 |
WO2006076455A3 (en) | 2006-12-07 |
GT200600011A (es) | 2006-08-10 |
NO20074052L (no) | 2007-09-12 |
HN2006001493A (es) | 2010-08-19 |
DOP2006000009A (es) | 2006-08-15 |
JP2008526975A (ja) | 2008-07-24 |
AR052557A1 (es) | 2007-03-21 |
PE20061118A1 (es) | 2006-10-13 |
CR9224A (es) | 2007-10-23 |
US20060154940A1 (en) | 2006-07-13 |
CA2593345A1 (en) | 2006-07-20 |
US7425630B2 (en) | 2008-09-16 |
IL184365A0 (en) | 2007-10-31 |
EP1838713A2 (en) | 2007-10-03 |
CN101142216A (zh) | 2008-03-12 |
EA200701500A1 (ru) | 2007-12-28 |
WO2006076455A2 (en) | 2006-07-20 |
TW200637865A (en) | 2006-11-01 |
AU2006204940A1 (en) | 2006-07-20 |
WO2006076455A8 (en) | 2006-11-02 |
KR20070114126A (ko) | 2007-11-29 |
MX2007008381A (es) | 2007-09-07 |
EA013968B1 (ru) | 2010-08-30 |
PA8659701A1 (es) | 2006-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0606115A2 (pt) | processos para a preparação de compostos éteres de pirazol [3,4-d] pirimidina | |
BRPI0923786C1 (pt) | compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos e composições farmacêuticas compreendendo ditos compostos | |
TW200637844A (en) | Processes for preparing aromatic ethers | |
MX2009005935A (es) | Compuestos biciclicos y su uso como anti-diabeticos. | |
MX2009010047A (es) | Compuestos quimicos. | |
MX2009010045A (es) | Compuestos quimicos. | |
TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
CL2008002076A1 (es) | Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades. | |
BRPI0606704A (pt) | derivados de piridinila e pirimidinila substituìdos como moduladores do metabolismo e o tratamento de distúrbios relacionados ao mesmo | |
AR053827A1 (es) | Composiciones de tigeciclina y metodos de preparacion | |
BRPI0512683A (pt) | compostos anti-virais | |
TN2011000245A1 (en) | Organic compounds | |
BR112013033182A2 (pt) | compostos imidazopiridinil-aminopiridina substituída | |
BRPI0911035B8 (pt) | ativadores de pirrolidinona glicoquinase | |
BRPI0512856A (pt) | métodos e reagentes para o tratamento de distúrbios metabólicos | |
GB0508318D0 (en) | Organic compounds | |
NO20090064L (no) | Pyrasoler som glucokinase aktivatorer | |
GB0508314D0 (en) | Organic compounds | |
JO2770B1 (en) | Organic compounds | |
BRPI0620229B8 (pt) | formulações farmaceuticas e processos de produção da ditas formulações | |
MX2010001126A (es) | Proceso para la sintesis de inhibidores de enzima de activacion de e1. | |
CL2011001122A1 (es) | Compuestos derivados de carbamatos de alquilheterociclos; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir o tratar dolores agudos o cronicos, patologias neurologicas y psiquiatricas, enfermedades cardiovasculares, entre otras. | |
DK1869038T3 (da) | Substituerede 5,6,7,8-tetrahydro-imidazol[1,2-a]pyridin-2-ylamin-forbindelser og deres anvendelse til fremstilling af lægemidler | |
WO2007115929A8 (de) | Thiazolyl-dihydro-quinazoline | |
CL2008001325A1 (es) | Compuestos derivados de pirazol-piridinona; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar inflamacion, enfermedad de paget, osteoartritis, alzheimer, entre otras enfermedades. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |